Sera Prognostics Reports Q3 Revenue of $42,000 and Net Loss of $8. ...
PreTRM test volume rises nearly five-fold from 1Q26, Florida adds Medicaid coverage, while net loss per share matches analyst expectations Related Stocks: SERA ,
PreTRM test volume rises nearly five-fold from 1Q26, Florida adds Medicaid coverage, while net loss per share matches analyst expectations Related Stocks: SERA ,